Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ginkgo Bioworks, Araceli Biosciences Add Cellular Imaging to Autonomous Lab

Ginkgo Bioworks, Araceli Biosciences Add Cellular Imaging to Autonomous Lab

MT newswireMT newswire2026/10/08 10:38

06:38 AM EDT, 10/08/2026 (MT Newswires) -- Ginkgo Bioworks (DNA) and Araceli Biosciences have integrated Araceli's Endeavor high-content imaging system into Ginkgo's Nebula autonomous laboratory in Boston, the companies said Thursday. The system can image a 1,536-well plate in less than four minutes and uses real-time analysis to evaluate each well as images are captured, they said. Financial terms of the partnership were not disclosed.

06:38 AM EDT, 10/08/2026 (MT Newswires) -- Ginkgo Bioworks (DNA) and Araceli Biosciences have integrated Araceli's Endeavor high-content imaging system into Ginkgo's Nebula autonomous laboratory in Boston, the companies said Thursday. The system can image a 1,536-well plate in less than four minutes and uses real-time analysis to evaluate each well as images are captured, they said. Financial terms of the partnership were not disclosed.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss